WHAT IS LUTETIUM THERAPY (177Lu-PSMA)?
The treatment with radioactive isotope 177Lu-PSMA is an effective treatment method for metastatic prostate cancer. 177Lu-PSMA therapy is used when treatment options with other approved methods have been exhausted, have proven ineffective, or the patient cannot tolerate them. The aim of the 177Lu-PSMA therapy is to reduce tumor volume, the rate of metastatic dissemination and other symptoms of the disease. "RSU Nuclear Medicine Clinic" is one of the few medical centers in the world that offers such an innovative treatment method.
WHAT IS THE EFFECT OF 177Lu-PSMA THERAPY?
The amount of prostate-specific membrane antigen (PSMA) increases significantly in prostate cancer cells, and if the prostate cancer has spread to other parts of the body, then PSMA expression will be detectable there, too. 177Lu-PSMA binds to PSMA receptors found on cancer cells, and radioactive isotope 177Lu destroys these cancer cells.